SCHEMBL881633

SCHEMBL881633

C=C(O[Si](C)(C)C)c1ccc2c(c1)OCCOCCOCCOCCOCCOc1cc-2ccc1C(=C)O[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 4/20 0.35
▸ LMNA P02545 3/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CSNK2A1 P68400 5/20 0.35
▸ CSNK2A2 P19784 2/20 0.33
▸ STK17A Q9UEE5 4/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ GAK O14976 1/20 0.32
▸ STK17B O94768 1/20 0.32
▸ BMP2K Q9NSY1 1/20 0.32
▸ HTT P42858 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ CLK1 P49759 1/20 0.32
▸ CHEK1 O14757 1/20 0.31
▸ CHEK2 O96017 1/20 0.31
▸ PDCD1 Q15116 2/20 0.30
▸ CD274 Q9NZQ7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10034797 0.93 KDM4E (0.38) KDM4EMAPTLMNAKMT2ACSNK2A1
SCHEMBL881347 0.86 KDM4E (0.44) KDM4EMAPTLMNAKMT2ANPSR1
SCHEMBL10067201 0.86 ALOX5 (0.37) KDM4EMAPTLMNAKMT2ACSNK2A1
SCHEMBL10034793 0.82 KDM4E (0.43) KDM4EMAPTLMNAKMT2ANPSR1
SCHEMBL10034796 0.82 POLB (0.35) KDM4EMAPTLMNAKMT2ACSNK2A1
SCHEMBL881625 0.74 KDM4E (0.61) KDM4EMAPTLMNAKMT2ACSNK2A1
SCHEMBL881622 0.69 KDM4E (0.41) KDM4EMAPTNPSR1HTTALDH1A1
SCHEMBL881325 0.62 KDM4E (0.78) KDM4EMAPTLMNAKMT2ANPSR1
SCHEMBL10034802 0.62 KDM4E (0.54) KDM4EMAPTLMNAKMT2ANPSR1
SCHEMBL21450877 0.61 POLB (0.54) KDM4EMAPTLMNAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012040389-A2 SUBSTITUTED BICYCLIC HCV INHIBITORS PRESIDIO PHARMACEUTICALS, INC. (US) 2012-03-29 — — WO disclosed
WO-2010111673-A1 SUBSTITUTED BICYCLIC HCV INHIBITORS PRESIDIO PHARMACEUTICALS, INC. (US) 2010-09-30 — — WO disclosed
Send feedback